22157.jpg
Comprehensive Review of Hospital Acquired Pneumonia (HAP) Clinical Trials 2024
28 mai 2024 09h38 HE | Research and Markets
Dublin, May 28, 2024 (GLOBE NEWSWIRE) -- The "Hospital Acquired Pneumonia (HAP) - Global Clinical Trials Review, 2024" report has been added to ResearchAndMarkets.com's offering.The extensive...
22157.jpg
Global Pulmonary Tuberculosis Clinical Trials Review 2024
28 mai 2024 09h26 HE | Research and Markets
Dublin, May 28, 2024 (GLOBE NEWSWIRE) -- The "Pulmonary Tuberculosis - Global Clinical Trials Review, 2024" report has been added to ResearchAndMarkets.com's offering.A comprehensive report...
22157.jpg
Global Juvenile Macular Degeneration Clinical Trials Review 2024, Featuring Lin Bioscience, Nanoscope Therapeutics, Alnylam Pharmaceuticals, Biophytis, Kubota Pharmaceutical and Nucleus Network
27 mai 2024 05h00 HE | Research and Markets
Dublin, May 27, 2024 (GLOBE NEWSWIRE) -- The "Juvenile Macular Degeneration (Stargardt Disease) - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's...
22157.jpg
Global Decompensated Cirrhosis Clinical Trials Review 2024, by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End Point Status
27 mai 2024 04h44 HE | Research and Markets
Dublin, May 27, 2024 (GLOBE NEWSWIRE) -- The "Decompensated Cirrhosis - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The clinical trial...
22157.jpg
Epilepsy Global Clinical Trials Review 2024 - Top Companies Participating in Epilepsy Therapeutics Clinical Trials
27 mai 2024 04h37 HE | Research and Markets
Dublin, May 27, 2024 (GLOBE NEWSWIRE) -- The "Epilepsy - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The clinical trial report provides...
visiongain Logo.png
Clinical Trial Supply and Logistics for Pharma market is projected to grow at a CAGR of 9.3% by 2034: Visiongain
27 mai 2024 04h00 HE | Visiongain Reports Ltd
Visiongain has published a new report entitled Clinical Trial Supply and Logistics Market for Pharma 2024-2034: Forecasts by Type (CTS Manufacturing, CTS Logistics & Distribution, CT Supply Chain,...
22157.jpg
Global Wet (Neovascular / Exudative) Macular Degeneration Clinical Trials Review 2024
27 mai 2024 02h49 HE | Research and Markets
Dublin, May 27, 2024 (GLOBE NEWSWIRE) -- The "Wet (Neovascular / Exudative) Macular Degeneration - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's...
22157.jpg
Clinical Trial Monitoring 2-Day Online Training Course: July 29-30, 2024 - Understand the Importance of Compliance with the Latest GCP Standards
24 mai 2024 07h40 HE | Research and Markets
Dublin, May 24, 2024 (GLOBE NEWSWIRE) -- The "Clinical Trial Monitoring Training Course" conference has been added to ResearchAndMarkets.com's offering. With regulatory inspectors increasingly...
Tourmaline_logo.jpg
Tourmaline Bio Initiates Clinical Development of TOUR006 for Cardiovascular Diseases with First Patient Dosed in Phase 2 TRANQUILITY Trial
16 mai 2024 07h00 HE | Tourmaline Bio, Inc.
Tourmaline Bio Initiates Clinical Development of TOUR006 for Cardiovascular Diseases with First Patient Dosed in Phase 2 TRANQUILITY Trial
NOVARTIS logo.jpg
Novartis highlights pioneering innovation in CML with data from Scemblix® Phase III ASC4FIRST study in newly diagnosed patients at ASCO and EHA
15 mai 2024 10h00 HE | Novartis Pharma AG
Primary results of the Scemblix® ASC4FIRST pivotal Phase III study in first-line Ph+ CML-CP supporting third US FDA Breakthrough Therapy designation, to be detailed in the ASCO Press Program and the...